| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10968377 | Vaccine | 2012 | 9 Pages |
Abstract
⺠We conduct an economic analysis of 2-dose and 3-dose rotavirus vaccination in Thailand. ⺠At current market prices of the vaccines, they are not cost-effective based on a cost-effectiveness threshold at 1 GDP per capita per DALYs averted. ⺠In a societal perspective, they will be cost-effective at US$4.98 and US$3.32 per dose for 2-dose and 3-dose vaccines, respectively. ⺠In a provider perspective, the price per dose must be US$2.90 and US$1.93 for 2-dose and 3-dose vaccines, respectively.
Keywords
IPDMinistry of Public HealthInvasive pneumococcal diseasesMOPHICERNVCEPINIPOPVDALYsNational Immunization ProgramExpanded Program on ImmunizationThailandCost-effectiveness analysisEconomic analysisRotavirusDisability-Adjusted Life YearsIncremental cost-effectiveness ratioHaemophilus influenzae type bHibVaccineOral polio vaccineHuman papillomavirusHPV
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Charung Muangchana, Arthorn Riewpaiboon, Suchada Jiamsiri, Piyanit Thamapornpilas, Porpit Warinsatian,